{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T08:50:24Z","timestamp":1765356624774,"version":"build-2065373602"},"reference-count":44,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmcd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.numecd.2019.10.013","type":"journal-article","created":{"date-parts":[[2019,11,8]],"date-time":"2019-11-08T12:06:02Z","timestamp":1573214762000},"page":"426-433","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Correction of QRS voltage for body mass index does not improve the prediction of fatal and nonfatal cardiovascular events. The Moli-sani study"],"prefix":"10.1016","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8101-1374","authenticated-orcid":false,"given":"Massimo","family":"Salvetti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Paini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Augusto","family":"Di Castelnuovo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deodato","family":"Assanelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4569-1186","authenticated-orcid":false,"given":"Simona","family":"Costanzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Gianfagna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabio","family":"Badilini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0370-1278","authenticated-orcid":false,"given":"Martino","family":"Vaglio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria B.","family":"Donati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"de Gaetano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4007-9441","authenticated-orcid":false,"given":"Maria","family":"Lorenza Muiesan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Licia","family":"Iacoviello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.numecd.2019.10.013_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00003495-198800355-00002","article-title":"Left ventricular hypertrophy: epidemiological insights from the Framingham heart study","volume":"35","author":"Levy","year":"1988","journal-title":"Drugs"},{"key":"10.1016\/j.numecd.2019.10.013_bib2","first-page":"1","article-title":"Epidemiology of heart disease in old age","author":"Caird","year":"1976","journal-title":"Cardiol Old Age"},{"key":"10.1016\/j.numecd.2019.10.013_bib3","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1097\/01.hjr.0000106836.977722.cf","article-title":"Relationship of electrocardiographic left ventricular hypertrophy to\u00a0mortality and cardiovascular morbidity in high-risk patients","volume":"10","author":"Lonn","year":"2011","journal-title":"Eur\u00a0J Cardiovasc Prev Rehabil"},{"key":"10.1016\/j.numecd.2019.10.013_bib4","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S0140-6736(09)61340-4","article-title":"Usual versus tight control of systolic blood pressure in non-diabetic patients with hypertension (Cardio-Sis): an open-label randomised trial","volume":"374","author":"Verdecchia","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.numecd.2019.10.013_bib5","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1161\/CIRCULATIONAHA.106.666594","article-title":"Regression of electrocardiographic left ventricular hypertrophy during antihypertensive therapy and reduction in sudden cardiac death: the LIFE study","volume":"116","author":"Wachtell","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.numecd.2019.10.013_bib6","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1001\/jama.296.10.1242","article-title":"Regression of electrocardiographic left ventricular hypertrophy and decreased incidence of new-onset atrial fibrillation in patients with hypertension","volume":"296","author":"Okin","year":"2006","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.numecd.2019.10.013_bib7","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.jelectrocard.2009.06.020","article-title":"Serial evaluation of electrocardiographic left ventricular\u00a0hypertrophy for prediction of risk in hypertensive patients","volume":"42","author":"Okin","year":"2009","journal-title":"J Electrocardiol"},{"key":"10.1016\/j.numecd.2019.10.013_bib8","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1161\/01.CIR.0000083724.28630.C3","article-title":"Regression of electrocardiographic left ventricular hypertrophy by losartan versus atenolol: the losartan intervention for endpoint reduction in hypertension (LIFE) study","volume":"108","author":"Okin","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.numecd.2019.10.013_bib9","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1161\/hc3901.096700","article-title":"Reduction of cardiovascular risk by regression of electrocardiographic markers of left ventricular hypertrophy by the angiotensin-converting enzyme inhibitor ramipril","volume":"104","author":"Mathew","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.numecd.2019.10.013_bib10","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1161\/01.CIR.90.4.1786","article-title":"Prognostic implications of baseline electrocardiographic features\u00a0and their serial changes in subjects with left ventricular hypertrophy","volume":"90","author":"Levy","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.numecd.2019.10.013_bib11","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1054\/jelc.2001.23360","article-title":"Independent risk for cardiovascular disease predicted by modified continuous score electrocardiographic criteria for 6-year incidence and regression of left ventricular hypertrophy among clinically disease free men: 16-year follow-up for the multiple risk","volume":"34","author":"Prineas","year":"2001","journal-title":"J Electrocardiol"},{"key":"10.1016\/j.numecd.2019.10.013_bib12","doi-asserted-by":"crossref","first-page":"311","DOI":"10.7326\/0003-4819-147-5-200709040-00006","article-title":"Regression of electrocardiographic left ventricular hypertrophy is associated with less hospitalization for heart failure in hypertensive patients","volume":"147","author":"Okin","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.numecd.2019.10.013_bib13","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1161\/CIRCIMAGING.111.964627","article-title":"Cardiac remodeling in obesity","volume":"6","author":"Aurigemma","year":"2013","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.numecd.2019.10.013_bib14","doi-asserted-by":"crossref","DOI":"10.1007\/s11906-015-0539-z","article-title":"Obesity and left ventricular hypertrophy: the hypertension connection","volume":"17","author":"Woodiwiss","year":"2015","journal-title":"Curr Hypertens Rep"},{"key":"10.1016\/j.numecd.2019.10.013_bib15","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.jacc.2013.03.062","article-title":"Obesity and its association to phenotype and clinical course in hypertrophic cardiomyopathy","volume":"62","author":"Olivotto","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.numecd.2019.10.013_bib16","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.jacc.2008.12.015","article-title":"AHA\/ACCF\/HRS recommendations for the standardization and interpretation of the electrocardiogram. Part V: electrocardiogram changes associated with cardiac chamber hypertrophy a scientific statement from the American heart association electrocardiography","volume":"53","author":"Hancock","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.numecd.2019.10.013_bib17","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1161\/01.CIR.67.4.907","article-title":"Geometric determinants of electrocardiographic left ventricular hypertrophy","volume":"67","author":"Devereux","year":"1983","journal-title":"Circulation"},{"key":"10.1016\/j.numecd.2019.10.013_bib18","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S0002-9149(97)89209-0","article-title":"Influence of obesity on the diagnostic value of electrocardiographic criteria for detecting left ventricular hypertrophy","volume":"77","author":"Abergel","year":"1996","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.numecd.2019.10.013_bib19","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/0735-1097(95)00421-1","article-title":"Electrocardiographic identification of left ventricular hypertrophy: test performance in relation to definition of hypertrophy and presence of obesity","volume":"27","author":"Okin","year":"1996","journal-title":"J Am Coll Cardiol"},{"issue":"Suppl. D","key":"10.1016\/j.numecd.2019.10.013_bib20","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1093\/eurheartj\/14.suppl_D.8","article-title":"Methods for detection of left ventricular hypertrophy: application to hypertensive heart disease","volume":"14","author":"Devereux","year":"1993","journal-title":"Eur Heart J"},{"key":"10.1016\/j.numecd.2019.10.013_bib21","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1093\/ajh\/hpu268","article-title":"R Wave in aVL lead is a robust index of left ventricular hypertrophy: a cardiac MRI study","volume":"28","author":"Courand","year":"2015","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.numecd.2019.10.013_bib22","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.amjcard.2012.03.016","article-title":"Relation between abdominal obesity, insulin resistance and left ventricular hypertrophy diagnosed by electrocardiogram and magnetic resonance imaging in hypertensive patients","volume":"110","author":"Vernooij","year":"2012","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.numecd.2019.10.013_bib23","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1160\/TH15-02-0177","article-title":"T-wave axis deviation is associated with biomarkers of low-grade inflammation: findings from the MOLI-SANI study","volume":"114","author":"Bonaccio","year":"2015","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.numecd.2019.10.013_bib24","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.3324\/haematol.2011.043042","article-title":"White blood cell count, sex and age are major determinants of heterogeneity of platelet indices in an adult general population: results from the MOLI-SANI project","volume":"96","author":"Santimone","year":"2011","journal-title":"Haematologica"},{"key":"10.1016\/j.numecd.2019.10.013_bib25","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.atherosclerosis.2012.11.010","article-title":"T-wave axis deviation, metabolic syndrome and estimated cardiovascular risk \u2013 in men and women of the MOLI-SANI study","volume":"226","author":"Rago","year":"2013","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.numecd.2019.10.013_bib26","doi-asserted-by":"crossref","DOI":"10.1097\/HJH.0000000000001121","article-title":"Obesity and ECG left ventricular hypertrophy","volume":"35","author":"Muiesan","year":"2017","journal-title":"J Hypertens"},{"key":"10.1016\/j.numecd.2019.10.013_bib27","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1542-474X.2009.00330.x","article-title":"Correlation relationship assessment between left ventricular hypertrophy voltage criteria and body mass index in 41,806 Swiss conscripts","volume":"14","author":"Ab\u00e4cherli","year":"2009","journal-title":"Ann Noninvasive Electrocardiol"},{"key":"10.1016\/j.numecd.2019.10.013_bib28","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0022-0736(96)80070-7","article-title":"Adjustment of ECG left ventricular hypertrophy criteria for body mass index and age improves classification accuracy: the effects of hypertension and obesity","volume":"29","author":"Norman","year":"1996","journal-title":"J Electrocardiol"},{"key":"10.1016\/j.numecd.2019.10.013_bib29","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.amjcard.2014.05.016","article-title":"Usefulness of QRS voltage correction by body mass index to improve electrocardiographic detection of left ventricular hypertrophy in patients with systemic hypertension","volume":"114","author":"Angeli","year":"2014","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.numecd.2019.10.013_bib30","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/jch.12678","article-title":"Does QRS voltage correction by body mass index improve the accuracy of electrocardiography in detecting left ventricular hypertrophy and predicting cardiovascular events in a general population?","volume":"18","author":"Cuspidi","year":"2016","journal-title":"J Clin Hypertens"},{"key":"10.1016\/j.numecd.2019.10.013_bib31","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.numecd.2008.11.009","article-title":"Dietary patterns, cardiovascular risk factors and C-reactive protein in a healthy Italian population","volume":"19","author":"Centritto","year":"2009","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.numecd.2019.10.013_bib32","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1080\/09637480500195066","article-title":"Six reasons why the waist-to-height ratio is a rapid and effective global indicator for health risks of obesity and how its use could simplify the international public health message on obesity","volume":"56","author":"Ashwell","year":"2005","journal-title":"Int J Food Sci Nutr"},{"key":"10.1016\/j.numecd.2019.10.013_bib33","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1097\/HJH.0b013e328364ca4c","article-title":"Practice guidelines for the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC): ESH\/ESC Task Force for the management of arterial hypertension","volume":"31","author":"Mancia","year":"2013","journal-title":"J Hypertens"},{"issue":"1 Pt 1","key":"10.1016\/j.numecd.2019.10.013_bib34","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1161\/01.HYP.35.1.13","article-title":"Effect of obesity on electrocardiographic left ventricular hypertrophy in hypertensive patients: the losartan intervention for endpoint (LIFE) reduction in hypertension study","volume":"35","author":"Okin","year":"2000","journal-title":"Hypertension"},{"key":"10.1016\/j.numecd.2019.10.013_bib35","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1161\/CIRCULATIONAHA.117.028388","article-title":"A novel \u03b1-calcitonin gene-related peptide analogue protects against end-organ damage in experimental hypertension, cardiac hypertrophy, and heart failure","volume":"136","author":"Aubdool","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.numecd.2019.10.013_bib36","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/S0002-9149(99)80116-7","article-title":"Quantitative measurement of normal and excessive (cor adiposum) subepicardial adipose tissue, its clinical significance, and its effect on electrocardiographic QRS voltage","volume":"76","author":"Shirani","year":"1995","journal-title":"Am J Cardiol"},{"issue":"2","key":"10.1016\/j.numecd.2019.10.013_bib37","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0022-0736(82)80003-4","article-title":"The electrocardiogram in obesity","volume":"15","author":"Eisenstein","year":"1982","journal-title":"J Electrocardiol"},{"key":"10.1016\/j.numecd.2019.10.013_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-0736(75)80031-8","article-title":"Quantitative analysis of the vectorcardiogram in obesity. The effects of weight reduction","volume":"8","author":"Brohet","year":"1975","journal-title":"J Electrocardiol"},{"key":"10.1016\/j.numecd.2019.10.013_bib39","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1097\/HJH.0000000000000085","article-title":"Accuracy and prognostic significance of electrocardiographic markers of left ventricular hypertrophy in a general population: findings from the Pressioni Arteriose Monitorate e Loro Associazioni population","volume":"32","author":"Cuspidi","year":"2014","journal-title":"J Hypertens"},{"key":"10.1016\/j.numecd.2019.10.013_bib40","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1097\/HJH.0000000000000882","article-title":"Prevalence and prognosis of ECG abnormalities in normotensive and hypertensive individuals","volume":"34","author":"Lehtonen","year":"2016","journal-title":"J Hypertens"},{"key":"10.1016\/j.numecd.2019.10.013_bib41","doi-asserted-by":"crossref","first-page":"85I","DOI":"10.1016\/0002-9149(87)90466-8","article-title":"Population implications of electrocardiographic left ventricular hypertrophy","volume":"60","author":"Kannel","year":"1987","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.numecd.2019.10.013_bib42","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/HJH.0b013e328364fb58","article-title":"Left-ventricular hypertrophy and obesity: a systematic review and metaanalysis of echocardiographic studies","volume":"32","author":"Cuspidi","year":"2014","journal-title":"J Hypertens"},{"key":"10.1016\/j.numecd.2019.10.013_bib43","doi-asserted-by":"crossref","DOI":"10.1017\/S0007114515002378","article-title":"Nut consumption is inversely associated with both cancer and total mortality in a Mediterranean population: prospective results from the Moli-sani study","author":"Bonaccio","year":"2015","journal-title":"Br J Nutr"},{"key":"10.1016\/j.numecd.2019.10.013_bib44","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.jelectrocard.2014.08.003","article-title":"Racial differences in the ECG \u2014 selected aspects","volume":"47","author":"Macfarlane","year":"2014","journal-title":"J Electrocardiol"}],"container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475319304120?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475319304120?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T16:11:13Z","timestamp":1760544673000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939475319304120"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":44,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["S0939475319304120"],"URL":"https:\/\/doi.org\/10.1016\/j.numecd.2019.10.013","relation":{},"ISSN":["0939-4753"],"issn-type":[{"type":"print","value":"0939-4753"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Correction of QRS voltage for body mass index does not improve the prediction of fatal and nonfatal cardiovascular events. The Moli-sani study","name":"articletitle","label":"Article Title"},{"value":"Nutrition, Metabolism and Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.numecd.2019.10.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Italian Society of Diabetology, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition, and the Department of Clinical Medicine and Surgery, Federico II University. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}